Pune, India -- (SBWire) -- 07/16/2018 --The Transient Ischemic Attack Market report provides detailed analysis on the current market scenario along with historical market trends, and correlations between the market dynamics and forecasts. The market size in report covers both the parameters of the market i.e. market by value and volume. Along with market size, the study segments the global transient ischemic attack market based on diagnosis, treatment, and age group, and end-user.
This section helps the reader to identify the high-growth segments and capitalize on growth opportunities as well as develop strategies for risk mitigation. The report also explores market dynamics such as drivers, trends, opportunities, and restraints, impacting the growth of the market segments. This section also highlights the key micro and macroeconomic factors influencing the growth of the market.
The global Transient Ischemic Attack Industry is expected to grow at a CAGR of 6.08% during the forecast period 2017–2023. Transient Ischemic Attack (TIA) is a neurological dysfunction that is caused due to loss of blood flow to the brain, retina, or the spinal cord region. The prime causes of transient ischemic attack are a loss of blood supply to the brain which may occur due to various reasons. Generally, blood clots are formed in the blood vessel causing the blockage (thrombosis).
Get Exclusive Sample Copy of Transient Ischemic Attack Market Report spread across 226 Premium Pages, Top 20 Companies Profile and Supported with 337 Tables and Figures is Available @ https://www.marketresearchfuture.com/sample_request/5025 .
As per the guidelines issued from the American Heart Association and American Stroke Association Stroke Council, patients that experience Transient Ischemic Attack (TIA) should undergo head imaging within 24 hours of symptom onset, preferably with magnetic resonance imaging, including diffusion sequences. MRI is a better imaging modality for diagnosis of TIA than Computed Tomography (CT).
Global Transient Ischemic Attack Market: Regional Segmentation
In this report, the global transient ischemic attack market has been segmented into five key regions namely, North America, South America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). North America and South America collectively dominate the transient ischemic attack market owing to the high healthcare expenditure, growing demand for diagnosis of chronic diseases, and well-developed technology. Apart from these two regions, Europe and APAC are the two other important markets for TIA. The MEA holds the least share of the global transient ischemic attack market owing to the presence of several poor and slow developing third-world countries in Africa.
Players Covered
Some of key the players operating in the transient ischemic attack market include Koninklijke Philips N.V. (Netherland), Stryker Corporation (U.S.), Johnson & Johnson Services Inc. (U.S.), Boston Scientific Corporation (Germany), Sanofi (France), Bayer AG (Germany), Pfizer Inc. (U.S.), Siemens AG (Germany), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories Inc. (U.S.), GE Healthcare (U.S.), Penumbra, Inc. (U.S.), Medtronic PLC (U.S.), Merck & Co., Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), LivaNova PLC (U.K), EnteroMedics Inc. (U.S.), ElectroCore Medical LLC (U.S.), Boston Scientific Corporation (US), Cyberonics, Inc. (US), NeuroMetrix, Inc.(U.S.), ImThera Medical (U.S.), and Inspire Medical Systems, Inc.(U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), and Esaote (Italy).
Major TOC for Transient Ischemic Attack Market Research Report – Forecast to 2023:
1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of Study
3.3 List Of Assumptions
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Increasing Preference For Minimally Invasive Procedures
5.2.2 Rising Prevalence Of Chronic Disorders
5.2.3 Improvement In Reimbursement Scenario
5.2.4 Rising Geriatric Population
5.3 Restraints
5.3.1 Rising Treatment Cost And Hospital Stay
5.3.2 Lack Of Skilled Physician
5.4 Opportunities
5.4.1 New Advancements In Catheterization Devices
5.4.2 Guide Wire Assisted Surgery In Elderly Population
5.1 Mega Trends
5.1.1 Telemedicine
5.2 Macroeconomic Indicators
5.3 Technology Trends & Assessment
TOC Continued….!
Ask Questions to Experts @ https://www.marketresearchfuture.com/enquiry/5025 .
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Transient Ischemic Attack Market by Treatment Surgery, Antiplatelet Medications, Anticoagulant Medications, Industry Analysis and Forecasts 2018 to 2023
The Global Transient Ischemic Attack Market has been segmented based on diagnosis, treatment, age group, end-user, and region. By diagnosis, the imaging technique segmented accounted for the largest market share in 2017. This segment is projected to witness the highest CAGR to cross a market share of USD 1.5 Billion by 2023.